Posts in Germany

Sysmex Inostics OncoBEAM™-EGFR Digital PCR Liquid Biopsy Demonstrates Two-fold Higher Detection of p.T790M Mutations in 183 NSCLC Patients in Comparison Study

May 30, 2019 1:51:00 PM
| 2 min read

HAMBURG, Germany and BALTIMORE, Maryland, May 30, 2019 /PRNewswire/ -- Sysmex Inostics announces the publication of clinical research conducted as part of the CIRculating CANcer (CIRCAN) Program at the Lyon Cancer Institute (Lyon, France) comparing ...

Read More →

Subscribe for Blog Updates

We take your privacy seriously, and you may opt-out at any time

* indicates required

Sysmex Inostics' SafeSEQ ER+/HER2- Breast Cancer Panel Demonstrates Equivalent Sensitivity to OncoBEAM™ Enhanced Digital PCR Technology for Detection of Mutations in Circulating Tumor DNA

May 28, 2019 1:45:00 PM |
3 min read

Sysmex Inostics´ OncoBEAM™ demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma

Feb 25, 2019 1:22:00 PM |
3 min read
Germany

Sysmex Inostics´ OncoBEAM™ circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers

Nov 5, 2018 1:26:00 PM |
4 min read

Information in accordance with Art. 13 GDPR: https://www.sysmex-inostics.com/data

Germany: Sysmex Inostics GmbH, Falkenried 88, D-20251 Hamburg, Germany. +49 40- 325907-0

United States: Sysmex Inostics, Inc., 1812 Ashland Ave Suite 500, Baltimore, Maryland 21205, USA.   +1-855-BEAM-DNA (232-6362)

Japan: Sysmex Corporation, 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan.   +81 78 265-0500
© Sysmex Inostics